Compare Herbalife Nutrition Ltd (HLF) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Herbalife Nutrition Ltd vs Nuwellis Inc — how do they compare? Herbalife Nutrition Ltd trades at $12.05 (market cap $1.27B), while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: Herbalife Nutrition Ltd is far larger — about 1165.1× Nuwellis Inc's market cap, and Herbalife Nutrition Ltd is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| HLF | NUWE | |
|---|---|---|
Market Cap | $1.27B | $1.09M |
Sector | Consumer Staples | Technology |
52-Week High | $19.96 | $527.46 |
52-Week Low | $7.75 | $2.80 |
Enterprise Value | $3.00B | -$722.58K |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HLF trades at $12.04, up 0.42% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.64, beating expectations of $0.607, and raised full-year guidance. Revenue for 2025 was $5.04 billion with a net income margin of 4.66%, while valuation ratios remain low with a P/E of 5.38 and P/S of 0.25. Recent news includes Herbalife's inclusion in TIME's America's Best Companies 2026 and a $1.45 billion debt refinancing completed in April 2026.
The outlook for HLF is cautiously optimistic due to strong earnings beats and strategic initiatives, but risks include high debt levels and competitive pressures. Analyst consensus is 57.69% buy, with institutional sentiment leaning positive amid ongoing business transformation efforts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Herbalife Nutrition Ltd
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
